Original article by Julia Medew
The Sydney Morning Herald – Page: 7 : 22-Jul-14
A new treatment called PaMZ has been shown to fight tuberculosis (TB) while still allowing anti-retroviral drugs to be used that target the human immunodeficiency virus (HIV). The 20th international congress on the Acquired Immunodeficiency Syndrome (AIDS) in Melbourne on 21 July 2014 heard from Global TB Alliance senior medical officer Daniel Everitt on the promising clinical trials. TB accounts for about 20% of all deaths among those suffering from HIV or AIDS. PaMZ may be widely available from 2018
CORPORATES
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT